🇺🇸 Ketoconazole tablet in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 3 reports (25%)
  2. Abdominal Pain — 1 report (8.33%)
  3. Arthralgia — 1 report (8.33%)
  4. Asthenia — 1 report (8.33%)
  5. Back Pain — 1 report (8.33%)
  6. Chest Pain — 1 report (8.33%)
  7. Chills — 1 report (8.33%)
  8. Cushing'S Syndrome — 1 report (8.33%)
  9. Disease Progression — 1 report (8.33%)
  10. Dizziness — 1 report (8.33%)

Source database →

Other Infectious Disease approved in United States

Frequently asked questions

Is Ketoconazole tablet approved in United States?

Ketoconazole tablet does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ketoconazole tablet in United States?

Purdue Pharma LP is the originator. The local marketing authorisation holder may differ — check the official source linked above.